GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human MYT1 kinase domain in complex with MK1775

Analyse Crystal structure of human MYT1 kinase domain in complex with MK1775 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5VD0
Type
protein
Length
293 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.13
Source
Homo sapiens
Molecule
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase
EC
2.7.11.1
UniProt
Q99640
Ligands
8X7
Pockets
2 · best druggability 0.70

Structure

x-ray diffraction · resolution 2.13 · 1 distinct chain · 38% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMembrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (EC 2.7.11.1)protein29338% helix, 18% strandQ99640

Ligands and binding sites

  • 8X7 · 1-[6-(2-hydroxypropan-2-yl)pyridin-2-yl]-6-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-2-(prop-2-en-1-yl)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one · ligand · chains A
  • PEG · Di(hydroxyethyl)ether · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15910.700.79628X7
2600.310.7615empty

Compared structures

  • 5VD0 · Crystal structure of human MYT1 kinase domain in complex with MK1775 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q99640 · AlphaFold monomer V2.0 prediction for membrane-associated tyrosine- and… · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.